Home Page Invitation Chairmen and Speakers Program Scientific Information
Abstract Submission General Information Registration Group Registration Social Program Accompanying Persons
    Accommodation On-line Hotel Reservation Contact us
 
 

ADVANCED SCIENTIFIC PROGRAMME

Thursday - June 22, 2006
9.00-13.00 POST GRADUATED COURSES
The main objective of each course is to fully expose practicing pulmonary physicians and pulmonary fellows to advanced and updated knowledge within the nine broad topics selected. Each course will be characterized by a small part dedicated to didactic lectures followed by practical demonstrations held by the major Italian experts in the field of interstitial lung diseases. There will be ample time for participants to interact with the speakers and to formulate their own questions.
Room 1 Histopathological differences and pattern recognition
M. Chilosi (I) - R. Murer (I)
Room 2 Imaging of ILDs
M. Maffessanti (I) - G. Dalpiaz (I)
Room 3 Bronchoalveolar lavage and flow cytometry
C. Agostini (I) - P. Rottoli (I)
Room 4 Integrated diagnostic protocols
S. Harari (I) - A. Sanduzzi (I)
Room 5 Pulmonary function testing in diagnostic and follow up procedures
V. Brusasco (I) - R. Pellegrino (I)
Room 6 Invasive diagnostic techniques
V. Poletti (I) - S. Gasparini (I)
Room 7 Case report
A. Pesci (I) - M. Schiavina (I)
Room 8 Mechanical ventilation in lung fibrosis
S. Nava (I) - L. Bigatello (USA)
Room 9 Protocols in lung transplantation: indications and follow up
P. Vitulo (I) – F. Rea (I)
 
Aula Magna

14.30–16.15 GENETICS AND MECHANISMS OF PATHOGENESIS IN ILDs
Chairmen: R.M. Du Bois (UK), C. Saltini (I)

14.30 – 15.05
Gene targets in ILD: from microarray to clinic
I. Rosas (USA)

15.05 – 15.40
Transgenic and gene knock out animal models in the understanding of ILDs
J. Gauldie (CND)

15.40 – 16.15
Role of oxidative stress in ILDs
A. Bast (NL)

16.15-16.45
Coffee Break

16.45-18.30 PATHOGENESIS OF IDIOPATHIC PULMONARY FIBROSIS
Chairmen: J. Gauldie (CN), D. Olivieri (I)

16.45 – 17.20
Altered apoptosis mechanisms in lung fibrosis and the roles of angiotensin
B. D. Uhal (USA)

17.20 – 17.55
New insights into the role played by fibroblasts in idiopathic pulmonary fibrosis
C. Vancheri (I)

17.55 – 18.30
Opening the degradome secrets linked with idiopathic pulmonary fibrosis
A. Pardo (MEX)

Friday - June 23, 2006

 

8.30-10.15 DIAGNOSTIC PROCEDURES AND FOLLOW UP IN ILDs
Chairmen: G.W. Canonica (I), E. Pozzi (I)

8.30 – 9.05
Different histopathological patterns in ILDs
M. Chilosi (I)

9.05 – 9.40
Role of pulmonary imaging in ILDs: what is its role and when is it diagnostic?
M. Maffessanti (I)

9.40 – 10.15
Is surgical lung biopsy essential to diagnose idiopathic pulmonary fibrosis?
L. Richeldi (I)

10.15 – 10.45
Coffee Break

10.45-12.30 CURRENT CLINICAL PROBLEMS IN ILDs
Chairmen: L. Allegra (I), T. E. King (USA)

10.45 – 11.20
Common and uncommon clinical presentations of sarcoidosis
M. Drent (NL)

11.20 – 11.55
How to define acute exacerbation in patients with IPF?
V. Poletti (I)

11.55 – 12.30
Collagen vascular lung diseases and ILDs of unknown origin: differences and similarities
U. Costabel (D)

Chairman: G.U. Di Maria (I)

12.30 – 13.10
What recent clinical trials can tell us about mechanisms in ILD? (*)
R. Du Bois (UK)
(*) This lecture is kindly supported by ACTELION

13.15-15.00 POSTER DISCUSSION
Chairmen: V. De Rose (I), C. Robalo Cordeiro (P)

13.15 – 15.00
Lunch

15.00-18.30 THE VASCULAR SIDE OF ILDs
Chairmen: U. Costabel (D), L. Carratù (I)

15.00 – 15.35
Angiogenesis and vascular remodelling in lung fibrosis
R.M. Strieter (USA)

15.35 – 16.10
Imaging of pulmonary hypertension
G. Dalpiaz (I)

16.10 - 16.45
Significance of pulmonary hypertension as one of spectrum of progression in patients with interstitial pneumonia and sarcoidosis
S. Nagai (JPN)

16.45–18.30
LUNG FIBROSIS: CURRENT UNDERSTANDING ON CLINICAL AND THERAPEUTIC APPROACHES
Unrestricted educational grant by Boehringer Ingelheim
Chairmen: R. Baughman (USA), N. Crimi (I)

16.45 – 17.20
Predictor factors of disease progression and survival
T. King (USA)

17.20 – 17.55
Accelerated versus slow progressive idiopathic pulmonary fibrosis.
Clinical behaviour and pathogenic mechanisms
M. Selman (MEX)

17.55 –18.30
Therapeutic protocols in IPF
C. Albera (I)
Saturday - June 24, 2006

Chairman: L.M. Fabbri

8.30 - 9.10
Novel therapeutics targets in idiopathic pulmonary fibrosis (*)
G. Laurent (UK)

9.15 –10.45 NEW THERAPEUTIC APPROACHES IN ILDs
Chairmen: V. Bellia (I), S. Marsico (I)

9.15 – 9.50
From pathogenesis to new therapeutic approaches
S. Kunkel (USA)

9.50 – 10.25
Treatment of IPF: current trends, controversies and perspectives
G. Raghu (USA)

10.25 – 10.45
Coffee Break

10.45 – 11.20
The impact of biologic drugs on fibrosing lung diseases
G. Semenzato (I)

11.20– 11.55
Difficult therapeutic issues in sarcoidosis
R.P. Baughman (USA)

11.55 – 12.30
Lung transplantation: patients characteristics and outcomes
P. Rottoli (I)

12.30 – 12.45
Concluding remarks
O. Sharma (USA)

12.15-13.45 IX CONFERENZA DEL CAPITOLO ITALIANO WASOG
Chairmen: G. Girbino (I), G. Rizzato (I)
(*) This lecture is kindly supported by Merck Sharp & Dohme